In Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., the US Court of Appeals for the Federal Circuit found personal jurisdiction and affirmed a preliminary injunction against a foreign biosimilar manufacturer that planned to distribute its product nationwide.
Source link
Federal Circuit Upholds Preliminary Injunction in BPCIA Litigation
